Sarcio Inc.
Beth Lindborg is currently the Chief Executive Officer at Sarcio Inc., where the focus is on using stem cell-derived cartilage cells to treat Osteoarthritis. Beth has had previous experience in various roles in companies such as SynerFuse, Cell Culture Company, and BRTI Life Sciences. Beth holds a Master of Business Administration in Medical Industry Leadership from the University of Minnesota-Carlson School of Management, as well as a M.S. in Molecular, Cellular Developmental Biology and Genetics from the University of Minnesota.
This person is not in any teams